In a 12-week randomized clinical trial involving 300 obese adults, participants receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg (approximately 5.7 pounds) compared to 0.8 kg (1.8 pounds) in the placebo group
Comprehensive Well-being Focus : Our commitment extends beyond B12 shots
Pharmacokinetics and Bioavailability Researchers have characterized the pharmacokinetic properties of 5-Amino-1MQ including its absorption, distribution, and metabolism
If you are also buying non-eligible FSA/HSA items, you are required to make a separate transaction
Swallowed 5-Amino-1MQ has to survive gut absorption and a heavy first pass through the liver
Initially focused on metabolism, research showed NNMT elevation with age/weight leads to fat accumulation, inefficiency, and NAD+ loss.[30][31] High NNMT correlates with insulin resistance and obesity in humans